Thermo Fisher Scientific Inc.
TMO
$469.28
$2.710.58%
NYSE
| 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.39B | 5.95B | 5.57B | 6.65B | 8.82B |
| Total Receivables | 10.04B | 9.82B | 9.63B | 9.80B | 9.43B |
| Inventory | 5.56B | 5.22B | 4.98B | 5.43B | 5.20B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.60B | 2.39B | 1.96B | 1.91B | 2.03B |
| Total Current Assets | 24.58B | 23.38B | 22.14B | 23.78B | 25.48B |
|
|
|||||
| Total Current Assets | 24.58B | 23.38B | 22.14B | 23.78B | 25.48B |
| Net Property, Plant & Equipment | 9.64B | 9.33B | 10.80B | 9.41B | 9.28B |
| Long-term Investments | 47.25B | 46.49B | 45.85B | 46.73B | 43.84B |
| Goodwill | 47.25B | 46.49B | 45.85B | 46.73B | 43.84B |
| Total Other Intangibles | 15.15B | 15.32B | 31.10B | 16.26B | 15.52B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.44B | 4.16B | 5.45B | 4.09B | 3.90B |
| Total Assets | 101.23B | 99.04B | 97.32B | 100.36B | 98.50B |
|
|
|||||
| Total Accounts Payable | 2.98B | 3.05B | 3.08B | 2.61B | 2.55B |
| Total Accrued Expenses | 4.64B | 4.38B | 4.88B | 5.16B | 4.46B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.21B | 2.82B | 2.48B | 4.12B | 5.12B |
| Total Finance Division Other Current Liabilities | 2.88B | 2.93B | 2.90B | 2.72B | 2.64B |
| Total Other Current Liabilities | 2.88B | 2.93B | 2.90B | 2.72B | 2.64B |
| Total Current Liabilities | 12.72B | 13.17B | 13.33B | 14.60B | 14.77B |
|
|
|||||
| Total Current Liabilities | 12.72B | 13.17B | 13.33B | 14.60B | 14.77B |
| Long-Term Debt | 33.23B | 31.24B | 28.93B | 31.20B | 30.10B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 196.00M | 200.00M | 1.43B | 200.00M | 207.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.49B | 4.94B | 3.96B | 5.27B | 5.88B |
| Total Liabilities | 50.63B | 49.56B | 47.65B | 51.27B | 50.96B |
|
|
|||||
| Common Stock & APIC | 18.68B | 18.56B | 18.41B | 18.28B | 18.09B |
| Retained Earnings | 55.90B | 54.45B | 53.10B | 51.42B | 49.94B |
| Treasury Stock & Other | -24.07B | -23.61B | -21.92B | -20.70B | -20.60B |
| Total Common Equity | 50.51B | 49.39B | 49.58B | 48.99B | 47.43B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 50.51B | 49.39B | 49.58B | 48.99B | 47.43B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 91.00M | 95.00M | 87.00M | 107.00M | 103.00M |
| Total Equity | 50.60B | 49.49B | 49.67B | 49.10B | 47.54B |
|
|
|||||